Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12832397 | 1.00 | ALOX15 (0.33) | ALOX15 | |
| SCHEMBL8158694 | 1.00 | ALOX15 (0.33) | ALOX15 | |
| SCHEMBL11992933 | 0.74 | ALOX15 (0.30) | ALOX15 | |
| SCHEMBL20355945 | 0.74 | ALOX15 (0.33) | ALOX15 | |
| SCHEMBL11994262 | 0.74 | ALOX15 (0.33) | ALOX15 | |
| SCHEMBL20349072 | 0.74 | ALOX15 (0.30) | ALOX15 | |
| SCHEMBL17705970 | 0.73 | ALOX15 (0.40) | ALOX15 | |
| SCHEMBL21011 | 0.73 | ALOX15 (0.42) | ALOX15 | |
| SCHEMBL10452493 | 0.73 | ALOX15 (0.42) | ALOX15 | |
| SCHEMBL10452597 | 0.73 | ALOX15 (0.42) | ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10888090-B2 | Plant growth promoters and methods of using them | KING ABDULLAH UNIVERSITY OF SCIENCE AND TECHNOLOGY (SA) | 2021-01-12 | — | — | US | disclosed |
| US-20180184651-A1 | PLANT GROWTH PROMOTERS AND METHODS OF USING THEM | KING ABDULLAH UNIVERSITY OF SCIENCE AND TECHNOLOGY (SA) | 2018-07-05 | — | — | US | disclosed |
| WO-2017125379-A1 | PROCESS FOR THE MAINTAINING OF A RATIO OF ISOMERS OF CAROTENOIDS | DSM IP ASSETS B.V. (NL) | 2017-07-27 | — | — | WO | disclosed |
| WO-2017001927-A1 | PLANT GROWTH PROMOTERS AND METHODS OF USING THEM | KING ABDULLAH UNIVERSITY OF SCIENCE AND TECHNOLOGY (SA) | 2017-01-05 | — | — | WO | disclosed |
| US-8834855-B2 | Sunscreen compositions comprising carotenoids | PROMAR AS (NO) | 2014-09-16 | — | — | US | disclosed |
| EP-1676925-B1 | Process for producing zeaxanthin and beta-cryptoxanthin | JX NIPPON OIL & ENERGY CORP (JP) | 2012-05-09 | — | — | EP | disclosed |
| EP-2133424-A1 | Peptide transporting to chromoplasts in petals and method of constructing plant having yellowish petals by using the same | KIRIN BEER KABUSHIKI KAISHA (JP) | 2009-12-16 | — | — | EP | disclosed |
| US-6111125-A | Preparation of (1R,4S)-4-hydroxy-1,2,2-trimethylcyclopentyl methyl ketone and derivatives and stereoisomers of this compound | BASF AKTIENGESELLSCHAFT (DE) | 2000-08-29 | — | — | US | disclosed |
| EP-0671378-B1 | Process for the preparation of (1R,4S)-4-hydroxy-1,2,2-trimethylcyclopentyl-methylketone, its derivatives and stereoisomers | BASF AG (DE) | 1997-01-29 | — | — | EP | disclosed |
| EP-0671378-A1 | Process for the preparation of (1R,4S)-4-hydroxy-1,2,2-trimethylcyclopentyl-methylketone, its derivatives and stereoisomers | BASF AKTIENGESELLSCHAFT (DE) | 1995-09-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180184651-A1 | PLANT GROWTH PROMOTERS AND METHODS OF USING THEM | MYB, CYC1, BLVRB | ALOX15 515/4885 |
| US-10888090-B2 | Plant growth promoters and methods of using them | MYB, CYC1, BLVRB | ALOX15 515/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.